A bill to avert a partial government shutdown that was backed by President-elect Trump failed to pass the House of Representatives on Thursday night. Congress is inching closer to the possibility of a partial shutdown,…
-
-
A bill to avert a partial government shutdown that was backed by President-elect Trump failed to pass the House of Representatives on Thursday night. Congress is inching closer to the possibility of a partial shutdown,…
-
Politics
US diplomats in Damascus for first time in more than 10 years following fall of Assad regime
A group of U.S. officials are in Syria’s capital for the first time in more than 10 years seeking information on American citizens who disappeared under the Assad regime, among other things. The team visiting…
-
The Islamic Republic of Iran has continued its pursuit of obtaining a nuclear weapon by not only stockpiling enriched uranium to near-weapons grade purity, it has expanded its covert actions in developing its weaponization capabilities. …
-
HIGHLIGHTS BBM trend now extends over 15km, from Awalé’s 100%-owned Fremen target in the south to the Boba and Fett targets in the north. Boba and Fett have been defined along strike from BBM, highlighting…
-
AgTech Company highlights recent 100% purchase of Hemp Carbon Standard platform to advance industrial hemp carbon credits global market opportunity Hempalta Corp. (TSXV: HEMP) (‘Hempalta’ or the ‘Company’) has released its financial results for the…
-
Investing
Opawica Explorations Inc Begins Field Work in Preparation of Upcoming Drill Campaign at Its Bazooka Property in the Abitibi Gold Belt
(TheNewswire) December 19th, 2024 TheNewswire – Vancouver, B.C. Opawica Explorations Inc. (TSXV: OPW) (FSE: A2PEAD) (OTCQB: OPWEF) (the ‘Company’ or ‘Opawica’) a Canadian mineral exploration company focused on precious and base metal projects, is pleased…
-
Forum Energy Metals Corp. (TSXV: FMC) (OTCQB: FDCFF) (‘Forum’ or the ‘Company’) announced today that the Company is not aware of any undisclosed material information that might be contributing to the recent decline in the…
-
Investing
PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx Addressing Patients with Recurrent Pericarditis
Cardiol Therapeutics President and CEO, David Elsley PRISM MarketView announces the release of an informative interview with Cardiol Therapeutics President and CEO, David Elsley, who discusses the company’s lead oral drug, CardiolRx, which is entering…
-
Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial Download the PDF here. This post appeared first on investingnews.com